Ribbon Acquisition Gets Nasdaq MVLS Deficiency Notice, 180 Days to Regain $35M Compliance
RIBB sits 24% above its 52-week low of $5.67.
Summary
Ribbon received a Nasdaq notice that its market value of listed securities has been under the $35 million minimum for 30 consecutive business days, with no fallback compliance under the equity or net income tests. It has until April 28, 2027 to cure, while its DRC Medicine business combination and depleted trust remain unresolved.
Key Events · Legal and Risk Events · RIBB
-
Nasdaq MVLS Deficiency Notice Received
On October 30, 2026 Nasdaq notified Ribbon that its market value of listed securities was below the $35,000,000 minimum under Rule 5550(b)(2) for 30 consecutive business days, from September 18 through October 29, 2026.
-
No Fallback Compliance Test Met
The notice states the company also does not satisfy the alternative continued listing requirements under Rules 5550(b)(1) (stockholders' equity) and 5550(b)(3) (net income from continuing operations), leaving no alternate path to compliance.
-
180-Day Cure Window to April 28, 2027
Ribbon has until April 28, 2027 to regain compliance, which requires MVLS to close at $35,000,000 or more for a minimum of 10 consecutive business days, with Nasdaq discretion to require up to 20.
-
Delisting Risk Overhangs Pending De-SPAC
The notice lands while the DRC Medicine business combination remains pending after the September 11, 2026 shareholder approval, when 68% of shares were redeemed for $36.6 million and the trust fell to $38.4 million against a going concern warning and $1.8 million working capital deficit.
Analysis · RIBB · Real Estate & Construction
Ribbon's market value of listed securities sat below Nasdaq's $35 million minimum for 30 straight business days, and the company also fails both fallback tests — stockholders' equity and net income from continuing operations — so there is no alternate route to compliance. That matters because this is a pre-closing SPAC: shareholders approved the DRC Medicine combination on September 11, 2026, but 68% of shares were redeemed for $36.6 million, and the trust was already down to $38.4 million with a going concern warning and a $1.8 million working capital deficit as of the Q2 10-Q. A delisting threat on top of a thin trust and a pending de-SPAC raises real doubt about whether the deal closes on the current timeline. The clock runs to April 28, 2027, and the cure requires MVLS to close at $35 million or more for at least 10 consecutive business days.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 49.5% of the 190 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RIBB was trading at $7.01 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $44M. The 52-week trading range was $5.67 to $18.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.